Dacarbazine with or without oblimersen (a Bcl-2 antisense oligonucleotide) in chemotherapy-naive patients with advanced melanoma and low-normal serum lactate dehydrogenase: 'The AGENDA trial'
Author:
|
Bedikian, Agop Y.; Garbe, Claus; Conry, Robert; Lebbe, Celeste; Grob, Jean J.
|
Tübinger Autor(en):
|
|
Published in:
|
Melanoma Research
(2014), Bd.
24,
H.
3,
S.
237-243
|
Verlagsangabe:
|
Lippincott Williams & Wilkins
|
Language:
|
English
|
Full text:
|
http://dx.doi.org/10.1097/CMR.0000000000000056
|
ISSN:
|
0960-8931
|
DDC Classifikation:
|
610 - Medicine and health
|
Dokumentart:
|
Article
|
Show full item record
|